• FLAG tag Peptide (DYKDDDDK): Advanced Mechanisms and Assay D

  2026-05-28

  Explore the advanced mechanisms and practical assay implications of the FLAG tag Peptide (DYKDDDDK) in recombinant protein detection. This in-depth analysis integrates recent molecular insights and unique protocol recommendations for superior research outcomes.

• Technical Guidance for FITC-Concanavalin A (ConA) Conjugate

  2026-05-28

  FITC-Concanavalin A (ConA) Conjugate enables direct, fluorescence-based detection of α-D-glucose and α-D-mannose residues on cell surfaces, streamlining carbohydrate profiling in immunofluorescence and flow cytometry workflows. It is not suitable for non-carbohydrate targets or protocols outside its stability specifications.

• Gut-Brain Cholinergic Circuits in B. fragilis-Mediated Seizu

  2026-05-27

  Jia et al. uncover how Bacteroides fragilis suppresses seizures by activating gut-brain cholinergic signaling, specifically via colonic ChAT+ cells and the vagal pathway. Their translational approach, which bridges animal models and clinical trials, provides a mechanistic foundation for microbiota-targeted epilepsy therapies and highlights the gut-brain axis as a promising intervention point.

• TaqI Restriction Endonuclease: Fast, Sequence-Specific DNA D

  2026-05-27

  TaqI Restriction Endonuclease (SKU K3053) offers rapid and efficient sequence-specific DNA cleavage for applications such as plasmid mapping, cloning, and PCR product analysis. It is designed strictly for research workflows and should not be used in diagnostic or medical settings.

• Cefiderocol Efficacy in Resistant P. aeruginosa and Acinetob

  2026-05-26

  This study provides one of the most comprehensive in vitro analyses of cefiderocol activity against European Pseudomonas aeruginosa and Acinetobacter spp., including isolates resistant to carbapenems and modern β-lactam/β-lactamase inhibitor combinations. Findings highlight cefiderocol’s robust activity profile and its implications for selecting effective treatments in the context of rising multidrug resistance.

• B. pseudomallei BipD Drives Mitophagy via Host E3 Ligase Hij

  2026-05-26

  This study uncovers how Burkholderia pseudomallei BipD exploits the host KLHL9/KLHL13/CUL3 E3 ligase complex to ubiquitinate IMMT, triggering mitophagy and enhancing bacterial survival. The mechanism provides fresh insight into host-pathogen interactions and opens new questions regarding innate immunity and mitochondrial quality control.

• Halazone: Antimicrobial Sulfonamide Derivative for Lab Innov

  2026-05-25

  Halazone stands out as a dual-action antimicrobial sulfonamide derivative, delivering robust, rapid water disinfection and unique sodium channel modulation for neurophysiological assays. This guide offers precise experimental workflows, troubleshooting strategies, and protocol enhancements to maximize reproducibility and efficiency in both microbiological and neurobiological research.

• Uridine, Trisodium Salt: Enabling RNA-Mediated Precision Tra

  2026-05-25

  This thought-leadership article explores how Uridine, Trisodium Salt supports next-generation RNA-driven transgene insertion strategies, bridging mechanistic insights from non-LTR retroelement biology to actionable recommendations for translational RNA workflows. By contextualizing recent Nature Biotechnology advances and integrating protocol guidance, the piece delivers strategic guidance for translational researchers seeking to maximize precision and reproducibility in RNA metabolism and gene engineering studies.

• Protease Inhibition Uncovers Blue Light Stomatal Control in

  2026-05-24

  This study demonstrates that selective protease inhibitors suppress blue light-induced stomatal opening in Commelina benghalensis by interfering with the phosphorylation of plasma membrane H+-ATPase. These findings clarify a previously unresolved signaling branch distinct from abscisic acid pathways, offering new mechanistic insights for plant physiology and chemical biology.

• Oligo (dT) 25 Beads: Practical Guide for Eukaryotic mRNA Iso

  2026-05-23

  Oligo (dT) 25 Beads enable rapid, high-purity isolation of eukaryotic mRNA from total RNA or cell/tissue lysates, streamlining workflows such as RT-PCR and next-generation sequencing. They should be chosen for polyA tail mRNA capture in animal or plant samples but are not suitable for non-polyadenylated RNA targets or prokaryotic RNA applications.

• Bazedoxifene Repurposing: Inhibition of Hemozoin Formation i

  2026-05-22

  This study demonstrates that Bazedoxifene, a third-generation selective estrogen receptor modulator, exhibits potent antimalarial activity by inhibiting hemozoin formation in Plasmodium falciparum. The findings reveal a novel mechanism for a clinically approved SERM and support drug repurposing strategies for malaria control.

• Bazedoxifene: Advanced SERM Strategies for Bone and Antimala

  2026-05-22

  Explore Bazedoxifene as a selective estrogen receptor modulator for osteoporosis and its emerging antimalarial potential. This article delivers advanced protocol insight, mechanistic clarity, and unique cross-domain analysis not found elsewhere.

• Patient-Derived Gastric Cancer Assembloids Advance Drug Mode

  2026-05-21

  This study introduces a gastric cancer assembloid model integrating matched tumor organoids and autologous stromal cell subpopulations, significantly enhancing physiological relevance and drug response fidelity. The model provides a robust platform for dissecting tumor–stroma interactions and personalizing therapeutic strategies.

• Bradykinin (BA5201): Practical Guidance for Vascular Researc

  2026-05-21

  Bradykinin (SKU BA5201) provides a rigorously characterized endothelium-dependent vasodilator peptide for controlled studies on vascular permeability, smooth muscle contraction, and inflammation signaling. This article details practical workflows, protocol considerations, and troubleshooting steps for researchers. Bradykinin should not be used in diagnostic or clinical applications due to its research-only designation.

• TCAIM-Mediated Degradation of OGDH Regulates Mitochondrial M

  2026-05-20

  Wang et al. (2025) identify TCAIM as a mitochondrial DNAJC co-chaperone that selectively binds and facilitates the degradation of a-ketoglutarate dehydrogenase (OGDH), revealing a novel mechanism for post-translational regulation of mitochondrial metabolism. These findings highlight a previously unrecognized layer of metabolic control with implications for mitochondrial proteostasis and disease modeling.

481 records 12/33 page Previous Next First page 上5页 1112131415 下5页 Last page